Global Meloxicam Drug Market Research Report 2020

Publisher Name :
Date: 14-Feb-2020
No. of pages: 123
Inquire Before Buying

This report focuses on Meloxicam Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Meloxicam Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Boehringer-Ingelheim

- TerSera Therapeutics

- Iroko Pharmaceuticals

- Apotex

- Yung Shin Pharmaceutical

- Breckenridge Pharmaceutical

- Zydus Pharmaceuticals

- Unichem Pharmaceuticals

- Strides Pharma

- Cipla

- Dr. Reddy's Laboratories

- Glenmark Pharmaceuticals

- Teva

- PuraCap Pharmaceutical

- TARO

- Lupin Pharmaceuticals

- Aurobindo Pharma

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Tablet

- Capsule

Segment by Application

- Osteoarthritis in adults (OA)

- Rheumatoid Arthritis in adults (RA)

- Pediatric patients

Global Meloxicam Drug Market Research Report 2020

Table of Contents
1 Meloxicam Drug Market Overview
1.1 Product Overview and Scope of Meloxicam Drug
1.2 Meloxicam Drug Segment by Type
1.2.1 Global Meloxicam Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Meloxicam Drug Segment by Application
1.3.1 Meloxicam Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Osteoarthritis in adults (OA)
1.3.3 Rheumatoid Arthritis in adults (RA)
1.3.4 Pediatric patients
1.4 Global Meloxicam Drug Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Drug Revenue 2015-2026
1.4.2 Global Meloxicam Drug Sales 2015-2026
1.4.3 Meloxicam Drug Market Size by Region: 2020 Versus 2026
2 Global Meloxicam Drug Market Competition by Manufacturers
2.1 Global Meloxicam Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Meloxicam Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Meloxicam Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Meloxicam Drug Manufacturing Sites, Area Served, Product Type
2.5 Meloxicam Drug Market Competitive Situation and Trends
2.5.1 Meloxicam Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Meloxicam Drug Players (Opinion Leaders)
3 Meloxicam Drug Retrospective Market Scenario by Region
3.1 Global Meloxicam Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Meloxicam Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Meloxicam Drug Market Facts & Figures by Country
3.3.1 North America Meloxicam Drug Sales by Country
3.3.2 North America Meloxicam Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meloxicam Drug Market Facts & Figures by Country
3.4.1 Europe Meloxicam Drug Sales by Country
3.4.2 Europe Meloxicam Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meloxicam Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Meloxicam Drug Sales by Region
3.5.2 Asia Pacific Meloxicam Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meloxicam Drug Market Facts & Figures by Country
3.6.1 Latin America Meloxicam Drug Sales by Country
3.6.2 Latin America Meloxicam Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Meloxicam Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Meloxicam Drug Sales by Country
3.7.2 Middle East and Africa Meloxicam Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Meloxicam Drug Historic Market Analysis by Type
4.1 Global Meloxicam Drug Sales Market Share by Type (2015-2020)
4.2 Global Meloxicam Drug Revenue Market Share by Type (2015-2020)
4.3 Global Meloxicam Drug Price Market Share by Type (2015-2020)
4.4 Global Meloxicam Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Meloxicam Drug Historic Market Analysis by Application
5.1 Global Meloxicam Drug Sales Market Share by Application (2015-2020)
5.2 Global Meloxicam Drug Revenue Market Share by Application (2015-2020)
5.3 Global Meloxicam Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Meloxicam Drug Business
6.1 Boehringer-Ingelheim
6.1.1 Corporation Information
6.1.2 Boehringer-Ingelheim Description, Business Overview and Total Revenue
6.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Boehringer-Ingelheim Products Offered
6.1.5 Boehringer-Ingelheim Recent Development
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Meloxicam Drug Production Sites and Area Served
6.2.2 TerSera Therapeutics Description, Business Overview and Total Revenue
6.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 TerSera Therapeutics Products Offered
6.2.5 TerSera Therapeutics Recent Development
6.3 Iroko Pharmaceuticals
6.3.1 Iroko Pharmaceuticals Meloxicam Drug Production Sites and Area Served
6.3.2 Iroko Pharmaceuticals Description, Business Overview and Total Revenue
6.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Iroko Pharmaceuticals Products Offered
6.3.5 Iroko Pharmaceuticals Recent Development
6.4 Apotex
6.4.1 Apotex Meloxicam Drug Production Sites and Area Served
6.4.2 Apotex Description, Business Overview and Total Revenue
6.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Apotex Products Offered
6.4.5 Apotex Recent Development
6.5 Yung Shin Pharmaceutical
6.5.1 Yung Shin Pharmaceutical Meloxicam Drug Production Sites and Area Served
6.5.2 Yung Shin Pharmaceutical Description, Business Overview and Total Revenue
6.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Yung Shin Pharmaceutical Products Offered
6.5.5 Yung Shin Pharmaceutical Recent Development
6.6 Breckenridge Pharmaceutical
6.6.1 Breckenridge Pharmaceutical Meloxicam Drug Production Sites and Area Served
6.6.2 Breckenridge Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Breckenridge Pharmaceutical Products Offered
6.6.5 Breckenridge Pharmaceutical Recent Development
6.7 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Meloxicam Drug Production Sites and Area Served
6.6.2 Zydus Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zydus Pharmaceuticals Products Offered
6.7.5 Zydus Pharmaceuticals Recent Development
6.8 Unichem Pharmaceuticals
6.8.1 Unichem Pharmaceuticals Meloxicam Drug Production Sites and Area Served
6.8.2 Unichem Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Unichem Pharmaceuticals Products Offered
6.8.5 Unichem Pharmaceuticals Recent Development
6.9 Strides Pharma
6.9.1 Strides Pharma Meloxicam Drug Production Sites and Area Served
6.9.2 Strides Pharma Description, Business Overview and Total Revenue
6.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Strides Pharma Products Offered
6.9.5 Strides Pharma Recent Development
6.10 Cipla
6.10.1 Cipla Meloxicam Drug Production Sites and Area Served
6.10.2 Cipla Description, Business Overview and Total Revenue
6.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Cipla Products Offered
6.10.5 Cipla Recent Development
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Meloxicam Drug Production Sites and Area Served
6.11.2 Dr. Reddy's Laboratories Meloxicam Drug Description, Business Overview and Total Revenue
6.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Dr. Reddy's Laboratories Products Offered
6.11.5 Dr. Reddy's Laboratories Recent Development
6.12 Glenmark Pharmaceuticals
6.12.1 Glenmark Pharmaceuticals Meloxicam Drug Production Sites and Area Served
6.12.2 Glenmark Pharmaceuticals Meloxicam Drug Description, Business Overview and Total Revenue
6.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Glenmark Pharmaceuticals Products Offered
6.12.5 Glenmark Pharmaceuticals Recent Development
6.13 Teva
6.13.1 Teva Meloxicam Drug Production Sites and Area Served
6.13.2 Teva Meloxicam Drug Description, Business Overview and Total Revenue
6.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Teva Products Offered
6.13.5 Teva Recent Development
6.14 PuraCap Pharmaceutical
6.14.1 PuraCap Pharmaceutical Meloxicam Drug Production Sites and Area Served
6.14.2 PuraCap Pharmaceutical Meloxicam Drug Description, Business Overview and Total Revenue
6.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 PuraCap Pharmaceutical Products Offered
6.14.5 PuraCap Pharmaceutical Recent Development
6.15 TARO
6.15.1 TARO Meloxicam Drug Production Sites and Area Served
6.15.2 TARO Meloxicam Drug Description, Business Overview and Total Revenue
6.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 TARO Products Offered
6.15.5 TARO Recent Development
6.16 Lupin Pharmaceuticals
6.16.1 Lupin Pharmaceuticals Meloxicam Drug Production Sites and Area Served
6.16.2 Lupin Pharmaceuticals Meloxicam Drug Description, Business Overview and Total Revenue
6.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Lupin Pharmaceuticals Products Offered
6.16.5 Lupin Pharmaceuticals Recent Development
6.17 Aurobindo Pharma
6.17.1 Aurobindo Pharma Meloxicam Drug Production Sites and Area Served
6.17.2 Aurobindo Pharma Meloxicam Drug Description, Business Overview and Total Revenue
6.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Aurobindo Pharma Products Offered
6.17.5 Aurobindo Pharma Recent Development
7 Meloxicam Drug Manufacturing Cost Analysis
7.1 Meloxicam Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meloxicam Drug
7.4 Meloxicam Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meloxicam Drug Distributors List
8.3 Meloxicam Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Meloxicam Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meloxicam Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Meloxicam Drug by Type (2021-2026)
10.2 Meloxicam Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meloxicam Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Meloxicam Drug by Application (2021-2026)
10.3 Meloxicam Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meloxicam Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Meloxicam Drug by Region (2021-2026)
10.4 North America Meloxicam Drug Estimates and Projections (2021-2026)
10.5 Europe Meloxicam Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Meloxicam Drug Estimates and Projections (2021-2026)
10.7 Latin America Meloxicam Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Meloxicam Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Meloxicam Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Meloxicam Drug Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Meloxicam Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Meloxicam Drug Manufacturers Covered in This Study
Table 5. Global Meloxicam Drug Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Meloxicam Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Meloxicam Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Meloxicam Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Meloxicam Drug Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Meloxicam Drug Sales Sites and Area Served
Table 11. Manufacturers Meloxicam Drug Product Types
Table 12. Global Meloxicam Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meloxicam Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Meloxicam Drug Players
Table 16. Global Meloxicam Drug Sales (K MT) by Region (2015-2020)
Table 17. Global Meloxicam Drug Sales Market Share by Region (2015-2020)
Table 18. Global Meloxicam Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Meloxicam Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Meloxicam Drug Sales by Country (2015-2020) (K MT)
Table 21. North America Meloxicam Drug Sales Market Share by Country (2015-2020)
Table 22. North America Meloxicam Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Meloxicam Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Meloxicam Drug Sales by Country (2015-2020) (K MT)
Table 25. Europe Meloxicam Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Meloxicam Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Meloxicam Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Meloxicam Drug Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Meloxicam Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Meloxicam Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Meloxicam Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Meloxicam Drug Sales by Country (2015-2020) (K MT)
Table 33. Latin America Meloxicam Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Meloxicam Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Meloxicam Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Meloxicam Drug Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Meloxicam Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Meloxicam Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Meloxicam Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 41. Global Meloxicam Drug Sales Share by Type (2015-2020)
Table 42. Global Meloxicam Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Meloxicam Drug Revenue Share by Type (2015-2020)
Table 44. Global Meloxicam Drug Price (USD/MT) by Type (2015-2020)
Table 45. Global Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 46. Global Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 47. Global Meloxicam Drug Sales Growth Rate by Application (2015-2020)
Table 48. Boehringer-Ingelheim Meloxicam Drug Corporation Information
Table 49. Boehringer-Ingelheim Description and Business Overview
Table 50. Boehringer-Ingelheim Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Boehringer-Ingelheim Main Product
Table 52. Boehringer-Ingelheim Recent Development
Table 53. TerSera Therapeutics Meloxicam Drug Corporation Information
Table 54. TerSera Therapeutics Corporation Information
Table 55. TerSera Therapeutics Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. TerSera Therapeutics Main Product
Table 57. TerSera Therapeutics Recent Development
Table 58. Iroko Pharmaceuticals Meloxicam Drug Corporation Information
Table 59. Iroko Pharmaceuticals Corporation Information
Table 60. Iroko Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Iroko Pharmaceuticals Main Product
Table 62. Iroko Pharmaceuticals Recent Development
Table 63. Apotex Meloxicam Drug Corporation Information
Table 64. Apotex Corporation Information
Table 65. Apotex Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Apotex Main Product
Table 67. Apotex Recent Development
Table 68. Yung Shin Pharmaceutical Meloxicam Drug Corporation Information
Table 69. Yung Shin Pharmaceutical Corporation Information
Table 70. Yung Shin Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Yung Shin Pharmaceutical Main Product
Table 72. Yung Shin Pharmaceutical Recent Development
Table 73. Breckenridge Pharmaceutical Meloxicam Drug Corporation Information
Table 74. Breckenridge Pharmaceutical Corporation Information
Table 75. Breckenridge Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Breckenridge Pharmaceutical Main Product
Table 77. Breckenridge Pharmaceutical Recent Development
Table 78. Zydus Pharmaceuticals Meloxicam Drug Corporation Information
Table 79. Zydus Pharmaceuticals Corporation Information
Table 80. Zydus Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Zydus Pharmaceuticals Main Product
Table 82. Zydus Pharmaceuticals Recent Development
Table 83. Unichem Pharmaceuticals Meloxicam Drug Corporation Information
Table 84. Unichem Pharmaceuticals Corporation Information
Table 85. Unichem Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Unichem Pharmaceuticals Main Product
Table 87. Unichem Pharmaceuticals Recent Development
Table 88. Strides Pharma Meloxicam Drug Corporation Information
Table 89. Strides Pharma Corporation Information
Table 90. Strides Pharma Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Strides Pharma Main Product
Table 92. Strides Pharma Recent Development
Table 93. Cipla Meloxicam Drug Corporation Information
Table 94. Cipla Corporation Information
Table 95. Cipla Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Cipla Main Product
Table 97. Cipla Recent Development
Table 98. Dr. Reddy's Laboratories Meloxicam Drug Corporation Information
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Dr. Reddy's Laboratories Main Product
Table 102. Dr. Reddy's Laboratories Recent Development
Table 103. Glenmark Pharmaceuticals Meloxicam Drug Corporation Information
Table 104. Glenmark Pharmaceuticals Corporation Information
Table 105. Glenmark Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Glenmark Pharmaceuticals Main Product
Table 107. Glenmark Pharmaceuticals Recent Development
Table 108. Teva Meloxicam Drug Corporation Information
Table 109. Teva Corporation Information
Table 110. Teva Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Teva Main Product
Table 112. Teva Recent Development
Table 113. PuraCap Pharmaceutical Meloxicam Drug Corporation Information
Table 114. PuraCap Pharmaceutical Corporation Information
Table 115. PuraCap Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. PuraCap Pharmaceutical Main Product
Table 117. PuraCap Pharmaceutical Recent Development
Table 118. TARO Meloxicam Drug Corporation Information
Table 119. TARO Corporation Information
Table 120. TARO Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. TARO Main Product
Table 122. TARO Recent Development
Table 123. Lupin Pharmaceuticals Meloxicam Drug Corporation Information
Table 124. Lupin Pharmaceuticals Corporation Information
Table 125. Lupin Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Lupin Pharmaceuticals Main Product
Table 127. Lupin Pharmaceuticals Recent Development
Table 128. Aurobindo Pharma Meloxicam Drug Corporation Information
Table 129. Aurobindo Pharma Corporation Information
Table 130. Aurobindo Pharma Meloxicam Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Aurobindo Pharma Main Product
Table 132. Aurobindo Pharma Recent Development
Table 133. Sales Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Meloxicam Drug Distributors List
Table 136. Meloxicam Drug Customers List
Table 137. Market Key Trends
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Global Meloxicam Drug Sales (K MT) Forecast by Type (2021-2026)
Table 141. Global Meloxicam Drug Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Meloxicam Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Meloxicam Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Meloxicam Drug Sales (K MT) Forecast by Application (2021-2026)
Table 145. Global Meloxicam Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Meloxicam Drug Sales (K MT) Forecast by Region (2021-2026)
Table 147. Global Meloxicam Drug Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Meloxicam Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Meloxicam Drug Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Meloxicam Drug
Figure 2. Global Meloxicam Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Meloxicam Drug Consumption Market Share by Application: 2020 VS 2026
Figure 6. Osteoarthritis in adults (OA)
Figure 7. Rheumatoid Arthritis in adults (RA)
Figure 8. Pediatric patients
Figure 9. Global Meloxicam Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Meloxicam Drug Sales Capacity (K MT) (2015-2026)
Figure 11. Global Meloxicam Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Meloxicam Drug Sales Share by Manufacturers in 2020
Figure 13. Global Meloxicam Drug Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Meloxicam Drug Revenue in 2019
Figure 15. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Meloxicam Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Meloxicam Drug Sales Market Share by Region in 2019
Figure 18. Global Meloxicam Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Meloxicam Drug Revenue Market Share by Region in 2019
Figure 20. North America Meloxicam Drug Sales Market Share by Country in 2019
Figure 21. North America Meloxicam Drug Revenue Market Share by Country in 2019
Figure 22. U.S. Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 23. U.S. Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 25. Canada Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Meloxicam Drug Sales Market Share by Country in 2019
Figure 27. Europe Meloxicam Drug Revenue Market Share by Country in 2019
Figure 28. Germany Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 29. Germany Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 31. France Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.K. Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 35. Italy Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 37. Russia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Meloxicam Drug Sales Market Share by Region in 2019
Figure 39. Asia Pacific Meloxicam Drug Revenue Market Share by Region in 2019
Figure 40. China Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 41. China Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 43. Japan Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 45. South Korea Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. India Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. Australia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. Taiwan Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 53. Indonesia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 55. Thailand Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 57. Malaysia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 59. Philippines Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 61. Vietnam Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Meloxicam Drug Sales Market Share by Country in 2019
Figure 63. Latin America Meloxicam Drug Revenue Market Share by Country in 2019
Figure 64. Mexico Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. Mexico Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. Brazil Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. Argentina Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Meloxicam Drug Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Meloxicam Drug Revenue Market Share by Country in 2019
Figure 72. Turkey Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Turkey Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Saudi Arabia Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Meloxicam Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. U.A.E Meloxicam Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Meloxicam Drug by Type (2015-2020)
Figure 79. Sales Market Share of Meloxicam Drug by Type in 2019
Figure 80. Revenue Share of Meloxicam Drug by Type (2015-2020)
Figure 81. Revenue Market Share of Meloxicam Drug by Type in 2019
Figure 82. Global Meloxicam Drug Sales Growth by Type (2015-2020) (K MT)
Figure 83. Global Meloxicam Drug Sales Market Share by Application (2015-2020)
Figure 84. Global Meloxicam Drug Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Meloxicam Drug by Application (2015-2020)
Figure 86. Global Revenue Share of Meloxicam Drug by Application in 2020
Figure 87. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. TerSera Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Yung Shin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Breckenridge Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Unichem Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. PuraCap Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. TARO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Price Trend of Key Raw Materials
Figure 105. Manufacturing Cost Structure of Meloxicam Drug
Figure 106. Manufacturing Process Analysis of Meloxicam Drug
Figure 107. Meloxicam Drug Industrial Chain Analysis
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. North America Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 112. North America Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Meloxicam Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Meloxicam Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs